RARE News

Pomerantz LLP Highlights Class Action Against Ultragenyx Pharmaceutical Inc. – RARE

Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Pomerantz LLP Alerts Shareholders to Investor Suit Involving Ultragenyx Pharmaceutical Inc. – RARE

RARE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026

RARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Calls Attention to Class Action Involving Ultragenyx Pharmaceutical Inc. – RARE

Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Ultragenyx Pharmaceutical Inc. – RARE

Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RARE

Pomerantz LLP Calls Attention to Class Action Filed Against Ultragenyx Pharmaceutical Inc. – RARE